A Study in Healthy Men to Test How BI 474121 is Tolerated

NCT04964453 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

32

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: Placebo
DRUG: BI 474121

Sponsor

Boehringer Ingelheim